Selected research
Industry Growth & Trends
Global Genomics & Sequencing Automation Systems Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Genomics & Sequencing Automation Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Genomics & Sequencing Automation Systems is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Genomics & Sequencing Automation Systems is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genomics & Sequencing Automation Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Genomics & Sequencing Automation Systems market include Agilent Technologies, Revvity, Roche Diagnostics, QIAGEN, Hamilton Company, Tecan, Becton Dickinson, Eppendorf and MGI Tech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Genomics & Sequencing Automation Systems market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Genomics & Sequencing Automation Systems market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genomics & Sequencing Automation Systems market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genomics & Sequencing Automation Systems.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Genomics & Sequencing Automation Systems market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Genomics & Sequencing Automation Systems Market by Company
Agilent Technologies
Revvity
Roche Diagnostics
QIAGEN
Hamilton Company
Tecan
Becton Dickinson
Eppendorf
MGI Tech
BGI Genomics
Autobio Diagnostics
Haier Biomedical
DAAN Gene
Illumina
Thermo Fisher Scientific
Danaher
Genomics & Sequencing Automation Systems Segment by Type
Automated Liquid Handling Systems
Automated Nucleic Acid Extraction Systems
NGS Library Preparation Automation Systems
Robotic Sample Processing Workstations
Integrated Genomics Automation Platforms
Sequencing Workflow Automation Systems
Genomics & Sequencing Automation Systems Segment by Application
Pharmaceutical and Biotechnology Companies
Clinical Diagnostic Laboratories
Academic and Research Institutes
Contract Research Organizations (CROs)
Government and Public Health Laboratories
Population Genomics Centers
Genomics & Sequencing Automation Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics & Sequencing Automation Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genomics & Sequencing Automation Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics & Sequencing Automation Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Genomics & Sequencing Automation Systems companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Liquid Handling Systems
- Automated Nucleic Acid Extraction Systems
- NGS Library Preparation Automation Systems
- Robotic Sample Processing Workstations
- Integrated Genomics Automation Platforms
- Sequencing Workflow Automation Systems
Applications
- Pharmaceutical and Biotechnology Companies
- Clinical Diagnostic Laboratories
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Government and Public Health Laboratories
- Population Genomics Centers
Companies covered
- Agilent Technologies
- Revvity
- Roche Diagnostics
- QIAGEN
- Hamilton Company
- Tecan
- Becton Dickinson
- Eppendorf
- MGI Tech
- BGI Genomics
- Autobio Diagnostics
- Haier Biomedical
- DAAN Gene
- Illumina
- Thermo Fisher Scientific
- Danaher
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Genomics & Sequencing Automation Systems Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Genomics & Sequencing Automation Systems Market Size by Region (2021-2032)
- 1.4.1 Global Genomics & Sequencing Automation Systems Market Size by Region (2021-2026)
- 1.4.2 Global Genomics & Sequencing Automation Systems Market Size by Region (2027-2032)
- 1.5 Key Regions Genomics & Sequencing Automation Systems Market Size (2021-2032)
- 1.5.1 North America Genomics & Sequencing Automation Systems Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Genomics & Sequencing Automation Systems Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Genomics & Sequencing Automation Systems Market Size Growth Rate (2021-2032)
- 1.5.4 South America Genomics & Sequencing Automation Systems Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Genomics & Sequencing Automation Systems Market Size Growth Rate (2021-2032)
2 Genomics & Sequencing Automation Systems Market by Type
- 2.1 Type Introduction
- 2.1.1 Automated Liquid Handling Systems
- 2.1.2 Automated Nucleic Acid Extraction Systems
- 2.1.3 NGS Library Preparation Automation Systems
- 2.1.4 Robotic Sample Processing Workstations
- 2.1.5 Integrated Genomics Automation Platforms
- 2.1.6 Sequencing Workflow Automation Systems
- 2.2 Global Genomics & Sequencing Automation Systems Market Size by Type
- 2.2.1 Global Genomics & Sequencing Automation Systems Market Size Overview by Type (2021-2032)
- 2.2.2 Global Genomics & Sequencing Automation Systems Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Genomics & Sequencing Automation Systems Market Size Forecasted by Type (2027-2032)
- 2.3 Global Genomics & Sequencing Automation Systems Market Size by Regions
- 2.3.1 North America Genomics & Sequencing Automation Systems Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Genomics & Sequencing Automation Systems Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Genomics & Sequencing Automation Systems Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Genomics & Sequencing Automation Systems Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Genomics & Sequencing Automation Systems Market Size Breakdown by Type (2021-2026)
3 Genomics & Sequencing Automation Systems Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical and Biotechnology Companies
- 3.1.2 Clinical Diagnostic Laboratories
- 3.1.3 Academic and Research Institutes
- 3.1.4 Contract Research Organizations (CROs)
- 3.1.5 Government and Public Health Laboratories
- 3.1.6 Population Genomics Centers
- 3.2 Global Genomics & Sequencing Automation Systems Market Size by Application
- 3.2.1 Global Genomics & Sequencing Automation Systems Market Size Overview by Application (2021-2032)
- 3.2.2 Global Genomics & Sequencing Automation Systems Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Genomics & Sequencing Automation Systems Market Size Forecasted by Application (2027-2032)
- 3.3 Global Genomics & Sequencing Automation Systems Market Size by Regions
- 3.3.1 North America Genomics & Sequencing Automation Systems Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Genomics & Sequencing Automation Systems Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Genomics & Sequencing Automation Systems Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Genomics & Sequencing Automation Systems Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Genomics & Sequencing Automation Systems Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Genomics & Sequencing Automation Systems Industry Trends
- 4.2 Genomics & Sequencing Automation Systems Industry Drivers
- 4.3 Genomics & Sequencing Automation Systems Industry Opportunities and Challenges
- 4.4 Genomics & Sequencing Automation Systems Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Genomics & Sequencing Automation Systems Revenue (2021-2026)
- 5.2 Global Genomics & Sequencing Automation Systems Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Genomics & Sequencing Automation Systems Key Company Headquarters & Area Served
- 5.4 Global Genomics & Sequencing Automation Systems Company, Product Type & Application
- 5.5 Global Genomics & Sequencing Automation Systems Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Genomics & Sequencing Automation Systems Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Genomics & Sequencing Automation Systems Players Market Share by Revenue in 2025
- 5.6.3 2025 Genomics & Sequencing Automation Systems Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Agilent Technologies
- 6.1.1 Agilent Technologies Company Information
- 6.1.2 Agilent Technologies Business Overview
- 6.1.3 Agilent Technologies Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Agilent Technologies Genomics & Sequencing Automation Systems Product Portfolio
- 6.1.5 Agilent Technologies Recent Developments
- 6.2 Revvity
- 6.2.1 Revvity Company Information
- 6.2.2 Revvity Business Overview
- 6.2.3 Revvity Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Revvity Genomics & Sequencing Automation Systems Product Portfolio
- 6.2.5 Revvity Recent Developments
- 6.3 Roche Diagnostics
- 6.3.1 Roche Diagnostics Company Information
- 6.3.2 Roche Diagnostics Business Overview
- 6.3.3 Roche Diagnostics Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Roche Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
- 6.3.5 Roche Diagnostics Recent Developments
- 6.4 QIAGEN
- 6.4.1 QIAGEN Company Information
- 6.4.2 QIAGEN Business Overview
- 6.4.3 QIAGEN Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 QIAGEN Genomics & Sequencing Automation Systems Product Portfolio
- 6.4.5 QIAGEN Recent Developments
- 6.5 Hamilton Company
- 6.5.1 Hamilton Company Company Information
- 6.5.2 Hamilton Company Business Overview
- 6.5.3 Hamilton Company Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Hamilton Company Genomics & Sequencing Automation Systems Product Portfolio
- 6.5.5 Hamilton Company Recent Developments
- 6.6 Tecan
- 6.6.1 Tecan Company Information
- 6.6.2 Tecan Business Overview
- 6.6.3 Tecan Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Tecan Genomics & Sequencing Automation Systems Product Portfolio
- 6.6.5 Tecan Recent Developments
- 6.7 Becton Dickinson
- 6.7.1 Becton Dickinson Company Information
- 6.7.2 Becton Dickinson Business Overview
- 6.7.3 Becton Dickinson Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Becton Dickinson Genomics & Sequencing Automation Systems Product Portfolio
- 6.7.5 Becton Dickinson Recent Developments
- 6.8 Eppendorf
- 6.8.1 Eppendorf Company Information
- 6.8.2 Eppendorf Business Overview
- 6.8.3 Eppendorf Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Eppendorf Genomics & Sequencing Automation Systems Product Portfolio
- 6.8.5 Eppendorf Recent Developments
- 6.9 MGI Tech
- 6.9.1 MGI Tech Company Information
- 6.9.2 MGI Tech Business Overview
- 6.9.3 MGI Tech Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 MGI Tech Genomics & Sequencing Automation Systems Product Portfolio
- 6.9.5 MGI Tech Recent Developments
- 6.10 BGI Genomics
- 6.10.1 BGI Genomics Company Information
- 6.10.2 BGI Genomics Business Overview
- 6.10.3 BGI Genomics Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 BGI Genomics Genomics & Sequencing Automation Systems Product Portfolio
- 6.10.5 BGI Genomics Recent Developments
- 6.11 Autobio Diagnostics
- 6.11.1 Autobio Diagnostics Company Information
- 6.11.2 Autobio Diagnostics Business Overview
- 6.11.3 Autobio Diagnostics Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Autobio Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
- 6.11.5 Autobio Diagnostics Recent Developments
- 6.12 Haier Biomedical
- 6.12.1 Haier Biomedical Company Information
- 6.12.2 Haier Biomedical Business Overview
- 6.12.3 Haier Biomedical Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Haier Biomedical Genomics & Sequencing Automation Systems Product Portfolio
- 6.12.5 Haier Biomedical Recent Developments
- 6.13 DAAN Gene
- 6.13.1 DAAN Gene Company Information
- 6.13.2 DAAN Gene Business Overview
- 6.13.3 DAAN Gene Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 DAAN Gene Genomics & Sequencing Automation Systems Product Portfolio
- 6.13.5 DAAN Gene Recent Developments
- 6.14 Illumina
- 6.14.1 Illumina Company Information
- 6.14.2 Illumina Business Overview
- 6.14.3 Illumina Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Illumina Genomics & Sequencing Automation Systems Product Portfolio
- 6.14.5 Illumina Recent Developments
- 6.15 Thermo Fisher Scientific
- 6.15.1 Thermo Fisher Scientific Company Information
- 6.15.2 Thermo Fisher Scientific Business Overview
- 6.15.3 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Product Portfolio
- 6.15.5 Thermo Fisher Scientific Recent Developments
- 6.16 Danaher
- 6.16.1 Danaher Company Information
- 6.16.2 Danaher Business Overview
- 6.16.3 Danaher Genomics & Sequencing Automation Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Danaher Genomics & Sequencing Automation Systems Product Portfolio
- 6.16.5 Danaher Recent Developments
7 North America
- 7.1 North America Genomics & Sequencing Automation Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 7.3 North America Genomics & Sequencing Automation Systems Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Genomics & Sequencing Automation Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 8.3 Europe Genomics & Sequencing Automation Systems Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Genomics & Sequencing Automation Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Genomics & Sequencing Automation Systems Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Genomics & Sequencing Automation Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 10.3 South America Genomics & Sequencing Automation Systems Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Genomics & Sequencing Automation Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Genomics & Sequencing Automation Systems Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Genomics & Sequencing Automation Systems Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst